| Schedule of Earnings Per Share, Basic and Diluted |
The following table sets forth the calculation of basic and diluted net income per common share for the periods presented: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2026 | | 2025 | | 2026 | | 2025 | | Numerator: | | | | | | | | Net income attributable to FTS | $ | 87,446 | | | $ | 29,942 | | | $ | 132,391 | | | $ | 29,122 | | Less: Undistributed earnings attributable to convertible preferred stockholders | — | | | (22,506) | | | — | | | (26,064) | | Net income attributable to common stockholders, basic and diluted | $ | 87,446 | | | $ | 7,436 | | | $ | 132,391 | | | $ | 3,058 | | | | | | | | | | | Denominator: | | | | | | | | Basic weighted average common shares attributable to FTS | 221,514,237 | | | 69,718,087 | | | 219,395,921 | | | 69,558,368 | | Add: effect of dilutive securities related to share-based payment awards (A) | 25,455,712 | | | 18,053,806 | | | 28,530,400 | | | 17,205,202 | | Diluted weighted average common shares attributable to FTS | 246,969,949 | | | 87,771,893 | | | 247,926,321 | | | 86,763,570 | | | | | | | | | | Net income per common share attributable to FTS, basic | $ | 0.39 | | | $ | 0.11 | | | $ | 0.60 | | | $ | 0.04 | | Net income per common share attributable to FTS, diluted | $ | 0.35 | | | $ | 0.08 | | | $ | 0.53 | | | $ | 0.04 | |
(A) The dilutive impact of share-based payment awards and warrants for the three months ended June 30, 2026 and 2025 comprised of 21,891,686 and 16,626,395 shares related to stock options, zero and 1,427,411 shares related to warrants and 3,564,026 and zero related to unvested RSUs, respectively. The dilutive impact of share-based payment awards and warrants for the six months ended June 30, 2026 and 2025 comprised of 23,853,506 and 15,902,257 shares related to stock options, zero and 1,302,945 shares related to warrants, and 4,676,894 and zero related to unvested RSUs, respectively. For the three and six months ended June 30, 2026, 3,205,942 and 1,602,971 shares, respectively, related to unvested options were excluded from the dilutive impact as those shares would have been anti-dilutive to the share count as of June 30, 2026. For the three and six months ended June 30, 2025, 3,110,889 and 2,950,318 shares, respectively, related to unvested RSUs were excluded from the dilutive impact as the issuance of those shares was contingent upon the satisfaction of a liquidity condition which was not satisfied as of the end of those periods.
|